Sentences with phrase «small biotech»

So I looked for postdoctoral positions as well as for positions in smaller biotech companies.

«I think there is more open opportunity in small biotech for people with an academic background,» he says.

Researchers in government and small biotech firms are trying to pick up some of the slack and are searching for agents that work in new ways.

They wanted to help the many small biotech companies devastated by the lack of venture capital funding since the financial crisis began in 2007.

He has consulted for three major pharmaceutical companies and is currently on the scientific advisory boards of two small biotech firms.

She participated in collaborations with small biotech companies and big pharma.

These include the BioRegio initiative, aimed at establishing a «competence network» in biotech, the BioFuture competition for young scientists, and BioChance for small biotech start - ups.

«Our client base within life sciences ranges from small biotech companies to global pharmaceutical giants — clients appreciate lawyers who are able adapt to changing environments, and who utilise their finely - honed critical and evaluative thinking skills in order to meet their needs.»

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease Source: Streetwise Reports (5/2/18) In the second of a two - part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and investors.

On November 21st, a relatively small biotech company named Gilead Sciences (GILD) made headline news in the pharmaceutical investment community when it acquired a little - known hepatitis C drug developer named Pharmasset Inc. (VRUS), for $ 10.8 billion, in an all - cash deal.

The «microbiome,» or the collection of organisms that reside within the human body (especially the gut), has become a big new interest area for a number of major pharma companies like Merck and smaller biotechs alike.

There's also significant investment supporting small biotech companies and Linear has invested substantially in attracting both the American and Chinese markets including engaging Mandarin speaking staff, translating materials and running meetings in Mandarin.

This makes the portfolio largely dependent on small companies for its overall returns, and as we saw with the SPDR, small biotechs made smart bets overall during the past year.

Most small biotechs have to publicize every step of their early research in a scramble to raise money, Moore notes.

And grant writing isn't necessarily out of the picture: Small biotech enterprises can apply for Small Business Innovation Research grants from NIH, the National Science Foundation, and the U.S. Department of Energy; the National Institute of Standards and Technology also offers funding for high - risk R&D through its Advanced Technology Program.

The approach comes at a time of renewed interest by large drugmakers in smaller biotech firms, with U.S. - based Celgene clinching a deal to buy Impact Biomedicines for up to $ 7 billion on Sunday and Japan's Takeda Pharmaceutical agreeing last week to buy another Belgian biotech group TiGenix for $ 630 million.

Many pharmaceutical companies continue to work on treatments for neurological diseases, as do many smaller biotech firms and academic medical research centers, and funding sources for these pursuits include private foundations as well as governments.

The move followed the company's acquisition of another biotech, KuDOS Pharmacetuicals, in 2005 and several agreements with small biotechs to co-develop drugs.

The reason some hiring managers are more critical of industry postdocs is that a number of smaller biotech companies consider positions at the postdoc level to be «cheap pairs of hands» jobs and not independent research positions.

Among the many small biotech firms and startups are Hydra Biosciences Inc., Momenta Pharmaceuticals Inc., Paragonix Technologies Inc., and Millenium, owned by Takeda Oncology, a Japanese pharmaceutical firm.

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease

BioSpyder Technologies, Inc. is a relatively small biotech company that features a potent assay for high - throughput gene expression profiling.

Lundbeckfonden Emerge is the early - stage investment unit of the Foundation, established to identify and invest in small biotech companies based on pioneering Danish - based research with commercial potential.

The lines between Big Pharma and small biotech are eroding.

Having those multiple partners is key, because one of the big risks any small biotech faces is that the partner decides to walk away from its development program — not surprising, since most drug development programs fail.

The head of Riot Blockchain, a small biotech company - turned - crypto, has made hundreds of thousands of dollars in stock sales already.

H.I.G.'s seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer.

The combination of these developments put the small biotech in much better financial shape.

With smaller biotechs having seen some incredible performance over the past year, it's not surprising to see the SPDR outperforming its iShares counterpart.

Julian was also CEO of a small biotech company.

«In terms of learning potential, I thought that there would be more to learn in a small biotech company than in big pharma,» he explains.

Follow Your Heart: A 5 - Year Journey in Science and Parenthood The arrival of her first child in the middle of an academic postdoc in a foreign country prompted Petra Schrotz to ask — and answer — some tough questions regarding her subsequent career path, deliberations that have led to a challenging and rewarding position in a small biotech company in Denmark.

In a small biotech firm, by contrast, «you are part of the whole picture and you're more involved in what goes on in the entire company.»

In 2006, Merck also bought two small biotech firms with which it had been partnering, GlycoFi of Lebanon, New Hampshire, and Abmaxis of Santa Clara, California.

So after completing his doctorate at Queen's University, Tabash took a friend's advice and applied for a postdoc position at Cytochroma Inc., a small biotech company based in Markham, Ontario.

But the aspect of the work I enjoy most, and one that I think differentiates research in a small biotech company from research in larger institutions and a great many university departments, is that competition is replaced by cooperation.

«In some respects, working in a small biotech is like climbing a steep ladder.

San Francisco - based Genentech, for example, started out as a small biotech in 1976.

Smaller biotech company GeneMedix has a plant in Ireland.

Seven years ago, when I completed my Ph.D. and joined a small biotech company, my assigned title was Scientist.

Clemmons currently works for a small biotech company in San Diego and recently founded SSC Enterprises, a consulting firm that concentrates on helping academic and industrial institutions successfully recruit, retain, and transition students of color into fulfilling science and engineering careers.

It's not big pharmaceutical companies driving the demand there, he says, but small biotech companies who've realized they can capitalize on the enormous amount of publicly available health and genomics data.

Giant pharmaceutical and smaller biotech firms are searching for epigenetic compounds to boost learning and memory.

«And smaller biotech companies are very interested in generating biomarkers, working on proof of concept, and testing in smaller patient populations.»

«A lot of small biotech companies have been affected by the economic situation.

«I think it may be up to smaller biotech companies and academia to come up with new drugs,» Littman says.

You need that kind of communication just to get anything done in a small biotech company, says Douglas Gjerde, CEO of San Jose, California - based PhyNexus.

So, when I go to visit a small biotech company in California that is very casual, it makes sense to be in the same kind of attire.

And animal advocates who want to influence business could consider investing in the small biotechs and large pharmaceutical companies that are working to develop alternatives to animals in research.